$91.4 Million is the total value of Asymmetry Capital Management, L.P.'s 29 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $4,423,000 | – | 86,577 | +100.0% | 4.84% | – |
| FATE | New | FATE THERAPEUTICS INC | $2,667,000 | – | 120,103 | +100.0% | 2.92% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $1,792,000 | – | 74,501 | +100.0% | 1.96% | – |
| QURE | New | UNIQURE NV | $1,534,000 | – | 32,331 | +100.0% | 1.68% | – |
| TXG | New | 10X GENOMICS INC-CLASS A | $1,533,000 | – | 24,603 | +100.0% | 1.68% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,469,000 | – | 15,016 | +100.0% | 1.61% | – |
| AVRO | New | AVROBIO INC | $1,331,000 | – | 85,554 | +100.0% | 1.46% | – |
| IMMU | New | IMMUNOMEDICS INC | $1,242,000 | – | 92,147 | +100.0% | 1.36% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $1,128,000 | – | 762,219 | +100.0% | 1.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.